Frontiers in Oncology | Breast Cancer

Original Research

Published on 01 Sep 2023

Changes in gut microbiota composition after 12 weeks of a home-based lifestyle intervention in breast cancer survivors during the COVID-19 lockdown

in Breast Cancer

Sabrina Donati Zeppa
Valentina Natalucci
Deborah Agostini
Luciana Vallorani
Stefano Amatori
Davide Sisti
Marco B. L. Rocchi
Valerio Pazienza
Francesco Perri
Annacandida Villani

Frontiers in Oncology

doi 10.3389/fonc.2023.1225645

3,930 views
5 citations

Original Research

Published on 01 Sep 2023

Prediction of axillary lymph node metastasis in early breast cancer patients with ultrasonic videos based deep learning

in Breast Cancer

Wei-Bin Li
Zhi-Cheng Du
Yue-Jie Liu
Jun-Xue Gao
Jia-Gang Wang
Qian Dai
Wen-He Huang

Frontiers in Oncology

doi 10.3389/fonc.2023.1219838

3,653 views
4 citations

Original Research

Published on 31 Aug 2023

Secretome profiling of Artemisia absinthium extract-loaded polymeric nanoparticle-treated MCF-7 and MDA-MB-231 revealed perturbation in microtubule assembly and cell migration

in Breast Cancer

Sana Kauser
Mohd Mughees
Irengbam Rocky Mangangcha
Sanskriti Swami
Saima Wajid

Frontiers in Oncology

doi 10.3389/fonc.2023.1209168

4,919 views
4 citations

Systematic Review

Published on 30 Aug 2023

Clinical utility of the pan-immune-inflammation value in breast cancer patients

in Breast Cancer

Xiaoyan Qi
Boyang Qiao
Tingting Song
Dan Huang
Hui Zhang
Yang Liu
Qi Jin
Ming Yang
Delong Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1223786

4,132 views
20 citations

Original Research

Published on 28 Aug 2023

PTCH1 and CTNNB1 emerge as pivotal predictors of resistance to neoadjuvant chemotherapy in ER+/HER2- breast cancer

in Breast Cancer

Gulnihal Ozcan

Frontiers in Oncology

doi 10.3389/fonc.2023.1216438

3,224 views
5 citations

Case Report

Published on 28 Aug 2023

Disitamab Vedotin (RC48) combined with bevacizumab for treatment of HR-negative/HER2-positive metastatic breast cancer with liver and brain involvement: A case report

in Breast Cancer

Fei Qu
Qian Liu
Rongrong Lu
Wei Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1245701

3,458 views
2 citations

Original Research

Published on 24 Aug 2023

A bibliometric analysis of metastatic breast cancer: two-decade report (2002-2022)

in Breast Cancer

Siyuan Jiang
Qingjie Meng
Fuqing Ji
Yulong Yin
Xianghua Liu
Wenzhen Shi
Yonggang Lyu

Frontiers in Oncology

doi 10.3389/fonc.2023.1229222

3,699 views
2 citations

Case Report

Published on 24 Aug 2023

Case Report: Ribociclib-induced phototoxicity presented as dyschromia with subsequent bullae formation

in Breast Cancer

Jyun-Yan Jhan
Wei-En Wang
Sung-Chao Chu
Chiu-Hsuan Cheng
Chung-Hsing Chang

Frontiers in Oncology

doi 10.3389/fonc.2023.1184738

2,760 views
3 citations

Review

Published on 22 Aug 2023

Validation of liquid biopsy for ESR1-mutation analysis in hormone-sensitive breast cancer: a pooled meta-analysis

in Breast Cancer

Omar Najim
Konstantinos Papadimitriou
Glenn Broeckx
Manon Huizing
Wiebren Tjalma

Frontiers in Oncology

doi 10.3389/fonc.2023.1221773

5,995 views
10 citations

Original Research

Published on 21 Aug 2023

Immune microenvironment dynamics in breast cancer during pregnancy: impact of gestational age on tumor-infiltrating lymphocytes and prognosis

in Breast Cancer

Elham Sajjadi
Konstantinos Venetis
Mariia Ivanova
Marianna Noale
Concetta Blundo
Eugenia Di Loreto
Giovanna Scarfone
Stefano Ferrero
Stefania Maggi
Paolo Veronesi

Frontiers in Oncology

doi 10.3389/fonc.2023.1116569

2,962 views
2 citations

Original Research

Published on 21 Aug 2023

Comparison of adverse effects of anti-tumor therapy for breast cancer shortly after COVID-19 diagnosis vs. the control period

in Breast Cancer

Mao Ding
Hongyu Xiang
Jingming Ye
Yuanjia Cheng
Qian Liu
Ling Xu

Frontiers in Oncology

doi 10.3389/fonc.2023.1203119

1,558 views
1 citation

Original Research

Published on 18 Aug 2023

GLS as a diagnostic biomarker in breast cancer: in-silico, in-situ, and in-vitro insights

in Breast Cancer

Danfeng Zhang
Man Wang
Xufeng Huang
Longbin Wang
Ying Liu
Shujing Zhou
Yidan Tang
Qi Wang
Zhengrui Li
Geng Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1220038

3,151 views
5 citations

Original Research

Published on 17 Aug 2023

HER-2 ultra-low breast cancer: exploring the clinicopathological features and prognosis in a retrospective study

in Breast Cancer

Jiajie Shi
Liqiu Zhang
Cuizhi Geng

Frontiers in Oncology

doi 10.3389/fonc.2023.1210314

3,240 views
4 citations

Original Research

Published on 17 Aug 2023

Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru

in Breast Cancer

Yomali Ferreyra
Gina Rosas
Alicia M. Cock-Rada
Jhajaira Araujo
Leny Bravo
Franco Doimi
Jhoysi Casas
María de los Ángeles Clavo
Joseph A. Pinto
Carolina Belmar-López

Frontiers in Oncology

doi 10.3389/fonc.2023.1227864

5,750 views
6 citations

Review

Published on 17 Aug 2023

Elucidating the roles of the mammary and gut microbiomes in breast cancer development

in Breast Cancer

Courtney Hoskinson
Rachel Yutong Jiang
Leah T. Stiemsma

Frontiers in Oncology

doi 10.3389/fonc.2023.1198259

3,993 views
4 citations

Original Research

Published on 16 Aug 2023

Impact of multidisciplinary team on the pattern of care for brain metastasis from breast cancer

in Breast Cancer

Fei Xu
Dan Ou
Weixiang Qi
Shubei Wang
Yiming Han
Gang Cai
Lu Cao
Cheng Xu
Jia-Yi Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1160802

1,707 views